DrugFeb 8, 2023
DISCOVERY PHARMA Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum recall — FDA D-0261-2023
CGMP deviations
Class IIFDA: TerminatedDISCOVERY PHARMA LLC
Overview of recall records associated with DISCOVERY PHARMA LLC, including dates, categories and classifications where available.
Classification mix: Class II: 1.
CGMP deviations
This page summarizes recall records in which the official source identifies DISCOVERY PHARMA LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.